Drawing for EXOSCAN

USPTO serial 79359047

EXOSCAN

Reviewed by CopyMark Law Group

Reg. 7341755Status 700Registered
Filing date
Status date
Registration date
Apr 2, 2024
Examiner
MORENO, PAUL A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EXOSCAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
040Providing advice related to the custom manufacture of biologics, pharmaceuticals, antibiotic medicines and materials for clinical trials and for commercial supply by pharmaceutical compoundersACTIVE
042Advisory services relating to industrial engineering in the field of manufacturing of biologics; technological development services, technology advice and information services and technical consultation services in the field of the production of biologics; providing scientific research information in the medical sector, in the field of clinical trialsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 27, 2024GPNXNOTIFICATION PROCESSED BY IB
May 3, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB
May 3, 2024FIMPFINAL DISPOSITION PROCESSED
May 2, 2024GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB
Apr 2, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 2, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 21, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 21, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 21, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 14, 2023ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Oct 17, 2023GPNXNOTIFICATION PROCESSED BY IB
Oct 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 27, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 27, 2023NPUBNOTICE OF PUBLICATION
Sep 10, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2023DOCKASSIGNED TO EXAMINER
Jun 4, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED
Jan 7, 2023MAFRAPPLICATION FILING RECEIPT MAILED
Jan 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance